{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:54:26Z","timestamp":1784768066389,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T00:00:00Z","timestamp":1484006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018550","name":"Lowy Medical Research Institute","doi-asserted-by":"publisher","award":["84134"],"award-info":[{"award-number":["84134"]}],"id":[{"id":"10.13039\/100018550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["PF-05231023"],"award-info":[{"award-number":["PF-05231023"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004807","name":"California Department of Fish and Game","doi-asserted-by":"publisher","award":["Li2650\/1-1"],"award-info":[{"award-number":["Li2650\/1-1"]}],"id":[{"id":"10.13039\/100004807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007914","name":"University of Texas Southwestern Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010305","name":"Bernadotte Foundation For Children\u2019s Eyecare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["305485 PREVENT-ROP"],"award-info":[{"award-number":["305485 PREVENT-ROP"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001209","name":"Knights Templar Eye Foundation","doi-asserted-by":"publisher","award":["76293"],"award-info":[{"award-number":["76293"]}],"id":[{"id":"10.13039\/100001209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY017017"],"award-info":[{"award-number":["EY017017"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY022275"],"award-info":[{"award-number":["EY022275"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY024864"],"award-info":[{"award-number":["EY024864"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 HD18655"],"award-info":[{"award-number":["P01 HD18655"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.celrep.2017.01.014","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T21:17:17Z","timestamp":1487107037000},"page":"1606-1613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice"],"prefix":"10.1016","volume":"18","author":[{"given":"Zhongjie","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffael","family":"Liegl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hsiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S.","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel B.","family":"Burnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Fredrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton C.","family":"Morss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Hellstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saswata","family":"Talukdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois E.H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2017.01.014_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/nyas.12412","article-title":"Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment","volume":"1311","author":"Abcouwer","year":"2014","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.celrep.2017.01.014_bib2","first-page":"20","article-title":"Intravitreal bevacizumab as anti-vascular endothelial growth factor in the management of complications of proliferative diabetic retinopathy","volume":"2","author":"Arevalo","year":"2013","journal-title":"Med. Hypothesis Discov. Innov. Ophthalmol."},{"key":"10.1016\/j.celrep.2017.01.014_bib3","first-page":"3016","article-title":"Mitochondrial abnormalities in ageing macular photoreceptors","volume":"42","author":"Barron","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.celrep.2017.01.014_bib4","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1038\/srep11382","article-title":"FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance","volume":"5","author":"Bernardo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2017.01.014_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of prematurity","volume":"10","author":"Chen","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1016\/j.celrep.2017.01.014_bib6","doi-asserted-by":"crossref","first-page":"e2970","DOI":"10.1136\/bmj.e2970","article-title":"Anti-vascular endothelial growth factor treatment for eye diseases","volume":"344","author":"Cheung","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.celrep.2017.01.014_bib7","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/diacare.26.9.2653","article-title":"Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies","volume":"26","author":"Ciulla","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.celrep.2017.01.014_bib8","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2017.01.014_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-6147(00)01676-X","article-title":"FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition","volume":"22","author":"Cross","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.celrep.2017.01.014_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cmet.2012.08.002","article-title":"\u03b2Klotho is required for fibroblast growth factor 21 effects on growth and metabolism","volume":"16","author":"Ding","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2017.01.014_bib11","article-title":"Idiopathic macular telangiectasia type 2: the progressive vasculopathy","author":"Engelbert","year":"2012","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.celrep.2017.01.014_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ando.2016.01.005","article-title":"Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients","volume":"77","author":"Esteghamati","year":"2016","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.celrep.2017.01.014_bib13","doi-asserted-by":"crossref","first-page":"162ra153","DOI":"10.1126\/scitranslmed.3004690","article-title":"Treating diabetes and obesity with an FGF21-mimetic antibody activating the \u03b2Klotho\/FGFR1c receptor complex","volume":"4","author":"Foltz","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2017.01.014_bib14","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3945\/ajcn.114.099291","article-title":"Dietary \u03c9-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin","volume":"101","author":"Fu","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.celrep.2017.01.014_bib15","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.bbadis.2016.05.002","article-title":"Review: adiponectin in retinopathy","volume":"1862","author":"Fu","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.celrep.2017.01.014_bib16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2017.01.014_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(97)01107-0","article-title":"Retinopathy of prematurity in middle-income countries","volume":"350","author":"Gilbert","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2017.01.014_bib18","doi-asserted-by":"crossref","first-page":"e0132643","DOI":"10.1371\/journal.pone.0132643","article-title":"Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice","volume":"10","author":"Gong","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2017.01.014_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2005.09.018","article-title":"Sequential induction of angiogenic growth factors by TNF-alpha in choroidal endothelial cells","volume":"171","author":"Hangai","year":"2006","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.celrep.2017.01.014_bib20","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/IAE.0000000000000082","article-title":"First symptoms and their age of onset in macular telangiectasia type 2","volume":"34","author":"Heeren","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.celrep.2017.01.014_bib21","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2017.01.014_bib22","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.109.194506","article-title":"Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-alpha expression","volume":"104","author":"Higuchi","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.celrep.2017.01.014_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/ATVBAHA.109.198465","article-title":"Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism","volume":"30","author":"Higuchi","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.celrep.2017.01.014_bib24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2017.01.014_bib25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1124\/jpet.113.204420","article-title":"Development of a novel long-acting antidiabetic FGF21 mimetic by targeted conjugation to a scaffold antibody","volume":"346","author":"Huang","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.celrep.2017.01.014_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nm.4059","article-title":"Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1","volume":"22","author":"Joyal","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2017.01.014_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neulet.2012.02.050","article-title":"Adiponectin receptor 1\u00a0gene (ADIPOR1) variant is associated with advanced age-related macular degeneration in Finnish population","volume":"513","author":"Kaarniranta","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.celrep.2017.01.014_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/dom.12408","article-title":"Fibroblast growth factor 21\u00a0analogue LY2405319 lowers blood glucose in streptozotocin-induced insulin-deficient diabetic mice by restoring brown adipose tissue function","volume":"17","author":"Kim","year":"2015","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.celrep.2017.01.014_bib29","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1167\/iovs.06-0407","article-title":"Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice","volume":"47","author":"Kociok","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.celrep.2017.01.014_bib30","first-page":"106594","article-title":"Animal models of diabetic retinopathy: summary and comparison","volume":"2013","author":"Lai","year":"2013","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.celrep.2017.01.014_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","article-title":"Risk factors and biomarkers of age-related macular degeneration","volume":"54","author":"Lambert","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.celrep.2017.01.014_bib32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","article-title":"Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice","volume":"17","author":"Lin","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2017.01.014_bib33","first-page":"929756","article-title":"Serum fibroblast growth factor 21 levels are correlated with the severity of diabetic retinopathy","volume":"2014","author":"Lin","year":"2014","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.celrep.2017.01.014_bib34","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.bbamcr.2012.05.017","article-title":"Inhibitory role of adiponectin peptide I on rat choroidal neovascularization","volume":"1823","author":"Lyzogubov","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.celrep.2017.01.014_bib35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/02713683.2012.676700","article-title":"Aqueous humor and plasma adiponectin levels in proliferative diabetic retinopathy patients","volume":"37","author":"Mao","year":"2012","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.celrep.2017.01.014_bib36","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1167\/iovs.15-16447","article-title":"Relationship between retinal blood flow and serum adiponectin concentrations in patients with type 2 diabetes mellitus","volume":"56","author":"Omae","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.celrep.2017.01.014_bib37","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/eye.2014.13","article-title":"A review of anti-VEGF agents for proliferative diabetic retinopathy","volume":"28","author":"Osaadon","year":"2014","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.celrep.2017.01.014_bib38","doi-asserted-by":"crossref","first-page":"26850","DOI":"10.1074\/jbc.M802787200","article-title":"Suppression of lipopolysaccharide-stimulated tumor necrosis factor-alpha production by adiponectin is mediated by transcriptional and post-transcriptional mechanisms","volume":"283","author":"Park","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2017.01.014_bib39","doi-asserted-by":"crossref","first-page":"546786","DOI":"10.1155\/2012\/546786","article-title":"Mechanism of inflammation in age-related macular degeneration","volume":"2012","author":"Parmeggiani","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.celrep.2017.01.014_bib40","first-page":"707","article-title":"The development of an experimental model of subretinal neovascularization in disciform macular degeneration","volume":"77","author":"Ryan","year":"1979","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.celrep.2017.01.014_bib41","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1182\/blood-2007-08-108597","article-title":"TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype","volume":"111","author":"Sainson","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2017.01.014_bib42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.celrep.2017.01.014_bib43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2016.01.006","article-title":"FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues","volume":"23","author":"Schlein","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2017.01.014_bib44","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.exer.2006.07.007","article-title":"Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization","volume":"83","author":"Shi","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.celrep.2017.01.014_bib45","first-page":"362","article-title":"Diabetes and retinal vascular dysfunction","volume":"9","author":"Shin","year":"2014","journal-title":"J.\u00a0Ophthalmic Vis. Res."},{"key":"10.1016\/j.celrep.2017.01.014_bib46","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.celrep.2017.01.014_bib47","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/me.2007-0313","article-title":"betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c","volume":"22","author":"Suzuki","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.celrep.2017.01.014_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","article-title":"A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2017.01.014_bib49","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.bbrc.2004.02.130","article-title":"Adiponectin differentially regulates cytokines in porcine macrophages","volume":"316","author":"Wulster-Radcliffe","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2017.01.014_bib50","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1210\/jc.2011-1930","article-title":"Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes","volume":"97","author":"Xiao","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2017.01.014_bib51","doi-asserted-by":"crossref","first-page":"e98130","DOI":"10.1371\/journal.pone.0098130","article-title":"FGF21 promotes endothelial cell angiogenesis through a dynamin-2 and Rab5 dependent pathway","volume":"9","author":"Yaqoob","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2017.01.014_bib52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/jcm4020343","article-title":"Age-Related Macular Degeneration: Advances in Management and Diagnosis","volume":"4","author":"Yonekawa","year":"2015","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.celrep.2017.01.014_bib53","doi-asserted-by":"crossref","first-page":"e82275","DOI":"10.1371\/journal.pone.0082275","article-title":"Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2017.01.014_bib54","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s12020-014-0413-9","article-title":"Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls","volume":"48","author":"Zibar","year":"2014","journal-title":"Endocrine"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124717300463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124717300463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:03:02Z","timestamp":1761904982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124717300463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S2211124717300463"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2017.01.014","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2017.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s).","name":"copyright","label":"Copyright"}]}}